首页> Experimental and therapeutic medicine> Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathways

Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathways

导出原文传递

翻译打印收藏纠错

第一作者： Deng, Qi

作者： Deng, Qi ^[1] ; Bai, Xue ; Lv, Hai-Rong ; Xiao, Xia ; Zhao, Ming-Feng ; Li, Yu-Ming

作者单位： Tianjin First Cent Hosp, Dept Hematol, Tianjin 300192, Peoples R China ^[1]

关键词 cytokine-induced killer rituximab human B-cell lymphoma cell lines K562 signaling pathway cell therapy

发布时间 2015-06-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Experimental and therapeutic medicine

2015年9卷4期

1215-1222页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Experimental and therapeutic medicine

2015年9卷4期

1215-1222页

检索历史清除

Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathways

Experimental and therapeutic medicine

相似文献

同项目论文

Experimental and therapeutic medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathways

Experimental and therapeutic medicine

相似文献

同项目论文

Experimental and therapeutic medicine

相关期刊

检索历史清除